Advertisement

Induction or Concurrent Chemotherapy and Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer

  • R. Komaki
  • J. D. Cox
Part of the Medical Radiology book series (MEDRAD)

Abstract

Thoracic radiation therapy was considered to be the standard care for patients with inoperable non-small cell lung cancer (NSCLC) in the United States for many years. Although the long-term results of such treatment were far from satisfactory (a large number of investigators reported approximately 1 patient of 20 treated survived 5 years), it was the only modality that offered any possibility of cure for patients with unresectable tumors. Over the past few years, combined chemotherapy and thoracic radiation therapy (TRT) have become standard treatment for patients with unresectable NSCLC if they have good performance status and minimal or no weight loss (SHAAKE-KONIG et al. 1992; DILLMAN et al. 1990; LECHEVALIER et al. 1991; SAUSE et al. 1995).

Keywords

Induction Chemotherapy Radiation Therapy Oncology Group Local Tumor Control Concurrent Chemotherapy Compare Radiation Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arriagada R, Le Chevalier T, Quoix E et al. (1991) Effect of chemotherapy on locally advanced nonsmall cell lung carcinoma: a randomized study of 353 patients. GETCB, FNCLCC, and CEBI trialists. Int J Radiat Oncol Biol Phys 20:1183–1190.PubMedCrossRefGoogle Scholar
  2. Begg AC, Hofland I, Moonen L et al. (1990) The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report. Int J Radiat Oncol Biol Phys 19:1449–1453.PubMedCrossRefGoogle Scholar
  3. Blanke C, Ansari R, Mantravadi R et al (1995) Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small cell lung cancer: a Hoosier Oncology Group protocol. J Clin Oncol 13:1425–1429.PubMedGoogle Scholar
  4. Byhardt RW, Scott C, Sause WT et al. (1998) Response, toxicity failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 42:469–478.PubMedCrossRefGoogle Scholar
  5. Cox JD, Pajak TF, Asbell S et al. (1993) Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group trials. Int J Radiat Oncol Biol Phys 27:493–498.PubMedCrossRefGoogle Scholar
  6. Cox JD, Scott CB, Emami B et al. (1997) Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials. Lung Cancer 18:126.CrossRefGoogle Scholar
  7. Coy P (1970) A randomized study of irradiation and vinblastine in lung cancer. Cancer 26:803–807.PubMedCrossRefGoogle Scholar
  8. Dillman RO, Seagren SL, Propert KJ et al. (1990) A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323:940–945.PubMedCrossRefGoogle Scholar
  9. Dillman RO, Herndon J, Seagren SL et al. (1996) Improved survival in stage III nonsmall cell lung cancer: seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst 88:1210–1216.PubMedCrossRefGoogle Scholar
  10. Early Breast Cancer Trials Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339:1–15, 71–85.Google Scholar
  11. Furuse K, Fukuoka M, Takada Y et al. (1997) A randomized phase III study of concurrent versus sequential thoracic radiotherapy (TRT) in combination of mitomycin (M), vindesine (V), and cisplatin (P) in unresectable stage III non-small cell lung cancer (NSCLC): preliminary analysis. Proc Am Soc Clin Oncol 16:459a.Google Scholar
  12. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S (1996) Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small cell lung cancer: a randomized study. J Clin Oncol 14:1065–1070.PubMedGoogle Scholar
  13. Komaki R, Scott C, Ettinger D et al. (1997a) Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92–04. Int J Radiat Oncol Biol Phys 38:149–155.PubMedCrossRefGoogle Scholar
  14. Komaki R, Scott CB, Sause WT et al. (1997b) Induction cisplatin/vinblastine and irradiation vs irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88–08/ECOG 4588. Int J Radiat Oncol Biol Phys 39:537–544Google Scholar
  15. LeChevalier T, Arriagada R, Quoix E et al (1991) Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer. First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 93:417–423Google Scholar
  16. LeChevalier T, Arriagada R, Tarayre M et al. (1992) Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma. J Natl Cancer Inst 84:58.CrossRefGoogle Scholar
  17. Lokich J, Chaffey J, Neptune W (1989) Concomitant 5-fluorouracil infusion and high dose radiation for stage III non-small cell lung cancer. Cancer 64:1021–1025.PubMedCrossRefGoogle Scholar
  18. Mattson K, Maasilta P (1989) Pulmonary toxicity. Lung Cancer 5:305–310.CrossRefGoogle Scholar
  19. Mattson K, Holsti LR, Holsti P et al. (1988) Inoperable non-small cell lung cancer: radiation with or without chemotherapy. Eur J Clin Oncol 3:477–482.CrossRefGoogle Scholar
  20. McMillan TJ, Hart IR (1986) Enhanced experimental metastatic capacity of a murine melanoma following pretreatment with anticancer drugs. Clin Exp Metastasis 4:285–292.PubMedCrossRefGoogle Scholar
  21. Morton RF, Jett JR, McGinnis I et al. (1991) Thoracic radiation therapy alone compared with combined chemoradio-therapy for locally unresectable nonsmall cell lung cancer. Ann Intern Med 115:681–686.PubMedGoogle Scholar
  22. Muggia FM, Louie AC, Sikic BI (1983) Pulmonary toxicity of antitumor agents. Cancer Treat Rev 10:221–243.PubMedCrossRefGoogle Scholar
  23. Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: metaanalysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 311:899–909.Google Scholar
  24. Phillips TL, Fu KK (1976) Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues. Cancer 37:1186–1200.PubMedCrossRefGoogle Scholar
  25. Sadeghi A, Payne D, Rubinstein L et al. (1988) Combined modality treatment for resected advanced non-small cell lung cancer: local control and local recurrence. Int J Radiat Oncol Biol Phys 15:89–97.PubMedCrossRefGoogle Scholar
  26. Sause WT, Scott CB, Taylor SG IV et al. (1995) RTOG 88–08 and ECOG 4588:Preliminary results of a phase III trial in regionally advanced unresectable non-small cell lung cancer. J Natl Cancer Inst 87:198–205.PubMedCrossRefGoogle Scholar
  27. Schaake-Konig C, van den Bogaert W, Dalesio O et al. (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 326:524–530.CrossRefGoogle Scholar
  28. Steel GG (1988) The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother Oncol 11:31–53.PubMedCrossRefGoogle Scholar
  29. Steel GG, Peckham MJ (1979) Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J. Radiat Oncol Biol Phys 5:85–91.PubMedGoogle Scholar
  30. Tannehill SP, Mehta MP, Larson M et al. (1997) Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial. J Clin Oncol 15:2850–2857.PubMedGoogle Scholar
  31. Tannock IF (1996) Treatment of cancer with radiation and drugs. J Clin Oncol 14:3156–3174.PubMedGoogle Scholar
  32. Trovo MG, Minatel E, Veronesi A et al. (1990) Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma. A randomized study. Cancer 65:400–404.Google Scholar
  33. Trovo NG, Minotel E, Fravelun G et al. (1992) Radiotherapy versus radiotherapy enhanced by cisplatin in Stage III non small cell lung cancer. Int J Radiat Oncol Biol Phys 24:11–16.PubMedCrossRefGoogle Scholar
  34. Tubiana M, Frindel E, Malaise E (1968) The application of radiobiologie knowledge and cellular kinetics to radiation therapy. Am J Roentgen Rad Ther Nucl Med 102:822–830.Google Scholar
  35. Umsawadi T, Valdivieso M, Barkley HT et al. (1985) Esophageal complications from combined chemoradiotherapy (cyclophosphamide + adriamycin + cisplatin + XRT) in the treatment of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 11:511–519.CrossRefGoogle Scholar
  36. von der Maase H (1986) Experimental studies on interactions of radiation and cancer chemotherapeutic drugs in normal tisues and solid tumour (review). Radiother Oncol 7:47–68.PubMedCrossRefGoogle Scholar
  37. von der Maase H, Overgaard J, Vaeth M (1986) Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice. Radiother Oncol 5:245–258.PubMedCrossRefGoogle Scholar
  38. Withers HR, Taylor JM, Maciejewski B (1988) The hazard of accelerated tumor donogen repopulation during radiotherapy. Acta Oncol 27:131–146.PubMedCrossRefGoogle Scholar
  39. Wolf M, Hans K, Becker H et al. (1994) Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced nonsmall cell lung cancer. Semin Oncol 21:42–47.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • R. Komaki
    • 1
  • J. D. Cox
    • 2
  1. 1.The University of Texas M.D. Anderson Cancer CenterHoustonUSA
  2. 2.Department of Radiation OncologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations